StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Management ChangeJul 2, 2026, 05:07 PM

LENZ Therapeutics Director Zach Scheiner Resigns

AI Summary

Zach Scheiner resigned from LENZ Therapeutics, Inc.'s Board of Directors and all committees, effective June 30, 2026. The company stated his resignation was not due to any dispute or disagreement. Following his departure, the Board reduced its size to six members and appointed Jeff George to the Audit Committee.

Key Highlights

  • Zach Scheiner resigned from LENZ Therapeutics' Board of Directors and all committees.
  • Resignation was effective immediately on June 30, 2026.
  • Dr. Scheiner's resignation was not due to any dispute or disagreement with the Company.
  • The Board decreased its size to six (6) members following the resignation.
  • Jeff George was appointed to the Audit Committee on June 30, 2026.
  • The Audit Committee now comprises Shelley Thunen, Frederic Guerard, and Jeff George.